r Although adenosine 2A (A 2A ) receptor activation triggers specific cell signalling cascades, the ensuing physiological outcomes depend on the specific cell type expressing these receptors. Abstract Cervical spinal adenosine 2A (A 2A ) receptor activation elicits a prolonged increase in phrenic nerve activity, an effect known as phrenic motor facilitation (pMF). The specific cervical spinal cells expressing the relevant A 2A receptors for pMF are unknown. This is an important question since the physiological outcome of A 2A receptor activation is highly cell type specific. Thus, we tested the hypothesis that the relevant A 2A receptors for pMF are expressed in phrenic motor neurons per se versus non-phrenic neurons of the cervical spinal cord. A 2A receptor immunostaining significantly colocalized with NeuN-positive neurons (89 ± 2%). Intrapleural siRNA injections were used to selectively knock down A 2A receptors in cholera toxin B-subunit-labelled phrenic motor neurons. A 2A receptor knock-down was verified by a ß45% decrease in A 2A receptor immunoreactivity within phrenic motor neurons versus non-targeting siRNAs (siNT; P < 0.05). There was no evidence for knock-down in cervical non-phrenic motor neurons. In rats that were anaesthetized, subjected to neuromuscular blockade and ventilated, pMF induced by cervical (C3-4) intrathecal injections of the A 2A receptor agonist CGS21680 was greatly attenuated in siA 2A (21%) versus siNT treated rats (147%; P < 0.01). There were no significant effects of siA 2A on phrenic burst frequency. Collectively, our results support the hypothesis that phrenic motor neurons express the A 2A receptors relevant to A 2A receptor-induced pMF.
Introduction
Although adenosine 2A (A 2A ) receptor activation elicits specific cell signalling cascades, the ensuing physiological outcomes depend on the specific cell type expressing these receptors. Consequently, Gs-protein-coupled A 2A receptors (Lee & Chao, 2001; Rajagopal et al. 2004) induce differential physiological responses in different brain regions. For example, neuronal A 2A receptor signalling in hippocampal CA3 pyramidal neurons is essential for some forms of long-term potentiation (Rebola et al. 2008) , whereas astrocytic A 2A receptor activation impairs memory in ageing mice (Orr et al. 2015) . Thus, A 2A receptor signalling may regulate vital physiological functions in a cell-specific manner, such as in the neural control of breathing.
Activation of cervical spinal A 2A receptors elicits a form of phrenic motor plasticity known as phrenic motor facilitation (pMF; Golder et al. 2008) ; pMF is a long-lasting increase in phrenic nerve activity caused by strengthening of spinal synaptic inputs to phrenic motor neurons. A 2A receptors are also required for phrenic motor plasticity triggered via physiological challenges, such as hypoxia. For instance, cervical spinal A 2A receptor activation is necessary for phrenic long-term facilitation following severe acute intermittent hypoxia (arterial P O 2 25-30 mmHg; (Nichols et al. 2012) . Although cervical spinal A 2A receptors play a significant role in modulating phrenic motor output, it is not known what cell type expresses the A 2A receptors relevant for pMF.
In the present study, we tested the hypothesis that the A 2A receptors relevant for pMF are expressed in phrenic motor neurons versus other neurons or nearby glia. We utilized neurophysiology, neuropharmacology, immunofluorescence and RNA interference targeting phrenic motor neurons to test: (1) intrapleural siRNA injections targeting A 2A receptors knock down phrenic motor neuron A 2A receptors, but not A 2A receptors in non-phrenic neurons of the cervical spinal cord; and (2) phrenic motor neuron A 2A receptor knock-down abolishes spinal A 2A receptor-induced pMF. Our collective observations support the hypothesis that the A 2A receptors relevant for pMF are expressed in phrenic motor neurons per se, versus other cells of the cervical spinal cord.
Methods

Ethical approval
All experiments were performed on adult male SpragueDawley rats between the ages of 3 and 4 months, weighing 300-400 g (Envigo, Indianapolis, IN, USA). All experimental protocols were approved by the University of Florida Institutional Animal Care and Use Committee and were conducted in accordance with the Animal Welfare Act, the Public Health Service Policy on Humane Care and Use of Laboratory Animals, and the NIH Guide for the Care and Use of Laboratory Animals (2011) . Rats were monitored regularly by trained staff, had access to food and water ad libitum and were exposed to 12 h light-dark cycle. All experimental interventions and protocols were conducted under anaesthesia to minimize the animals' pain and suffering. All intrapleural injections were performed under isoflurane (3% induction, 2-2.5% maintenance) and in all neurophysiological measurements rats were induced and kept under isoflurane (3% induction and maintenance) and later converted to urethane (2.1 g kg −1 , intravenous). During intrapleural injections and transcardial perfusions, the absence of toe pinch and corneal reflexes was maintained. In the neuromuscularly blocked terminal procedures, the absence of blood pressure and heart rate responses to the toe pinch and corneal reflexes were maintained. Animals were sacrificed via either transcardial perfusion or anaesthetic overdose permanently terminating heart rate, blood pressure and phrenic activity. The investigators understand the ethical principles under which The Journal of Physiology operates and their work complies with The Journal's animal ethics checklist (Grundy, 2015) .
Experimental design
A total of 34 rats were studied. Different rats were used for immunofluorescence (n = 14) and neurophysiology (n = 20) experiments to minimize potential carry-over effects.
In immunofluorescence experiments, we tested the hypothesis that A 2A receptor expression is knocked down within phrenic motor neurons, but not in non-phrenic cervical neurons or glia after intrapleural A 2A receptor siRNA injections. In neurophysiological experiments, we tested the hypothesis that intrathecal A 2A receptor agonist-induced pMF is attenuated by intrapleural siRNA injections targeting A 2A receptors.
siRNAs
Rats were injected with either non-targeting or targeting pools of siRNAs (Dharmacon Inc., Lafayette, CO, USA). Accell-modified siRNAs were used for their preferential transfection of neurons (Nakajima et al. 2012 
Experimental protocol
Phrenic motor neurons were retrogradely labelled via intrapleural injections of the β-subunit of cholera toxin (CtB) as described previously (Mantilla et al. 2009; Devinney et al. 2015; Dale et al. 2017) . Fifteen microlitres of cholera toxin subunit B (30 μl total per animal, 2 μg μl −1 in sterile H 2 O) was injected intrapleurally on each side using 25 μl Hamilton syringes at a depth of 6 mm through the fifth intercostal space anterior axillary line 7 days prior to tissue harvest. Intrapleural siRNA injections have been used previously to successfully knock down gene expression exclusively within phrenic motor neurons (Mantilla et al. 2013; Devinney et al. 2015; Dale et al. 2017) . siRNAs were injected for three consecutive days under brief isoflurane anaesthesia (2-2.5% in O 2 ) as bilateral 30 μl injections (2 × 30 μl of 5 μM siRNA via 50 μl Hamilton syringes) followed by tissue harvesting or neurophysiology experiments the day after the final injection (Fig. 1A) . No signs of pneumothorax were observed in any rats following injections.
Immunohistochemistry and image acquisition
Rats dedicated to the immunofluoresence studies were transcardially perfused ß24 h after the last siRNA injection using 0.01 M PBS at 4°C followed by 4% paraformaldehyde in 0.01 M PBS (pH 7.4). Spinal cords were harvested, post-fixed in 4% paraformaldehyde in 0.01 M PBS (pH 7.4) overnight and cryoprotected in 20% followed by 30% sucrose solutions. Following blocking of the C3-C5 spinal segment, transverse slices (40 μm) were sectioned using a freezing microtome (SM2010R, Leica, Buffalo Grove, IL, USA). The slices were kept in antifreeze solution (30% glycerol + 30% ethylene glycol in 0.1 M PBS) at −20°C. Phrenic motor neuronal A 2A receptor labelling was evaluated using every eighth spinal cord slice (a total of 12-16 sections per animal). Non-phrenic motor neuronal intensities were assessed in six sections per animal. 
Figure 1. Experimental and analytical protocols
A, cholera toxin B-fragment was injected intrapleurally at day 1 to selectively label phrenic motor neurons. Beginning 3 days later, non-targeting and targeting siRNAs were injected for 3 consecutive days. Rats were assigned to either immunofluoresence or terminal neurophysiology experiments and tested on day 7. B, A 2A receptor labelling intensity was assessed in the phrenic nucleus (red) and non-phrenic C3-C5 motor neurons. The distance of each motor neuron to the centre of mass of phrenic motor nucleus was also calculated (green). Background labelling was calculated as the median value over a region dorsomedial to the phrenic nucleus. C, sample histogram showing the distribution of phrenic and background A 2A receptor optical densities. Phrenic nucleus intensity was calculated using a circular region of interest (diameter: 100 µm). Non-phrenic motor neurons were identified by their size (>300 µm 2 ) and individually analysed.
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Spinal cord slices were washed thrice with 0.1% Triton X-100 in 0.05 M Tris-buffered saline (TBS-Tx) and underwent antigen retrieval using citrate solution (pH 6.0) at 80°C for 40 min. For immunofluorescence, tissues were blocked with 1% H 2 O 2 for 30 min and 5% normal donkey and normal horse serum in TBS-Tx for 1 h. Tissues were then incubated with primary antibodies at 4°C overnight, including: mouse anti-A 2A receptor (1:500, catalogue no: 05-717, Millipore, Billerica, MA, USA), goat anti-CtB (1:2000, catalogue no: 227040, Millipore) for phrenic motor neuronal studies, and/or rabbit anti-NeuN (1:500, catalogue no: ABN78, Millipore) for non-phrenic cervical motor neuron studies. A 2A antibody was previously validated by the absence of immunostaining in A 2A knock-out mice (Day et al. 2003; Orr et al. 2015) . In western blots, A 2A receptor antibody gives ß45 and ß42 kDa bands corresponding to glycosylated and unglycosylated receptor isoforms (Rosin et al. 1998) . Specificity of CtB antibody was shown via the absence of staining in cervical spinal cords of the non-CtB-injected rats. Following the incubation with primary antibodies, tissues were washed thrice in TBS-Tx and incubated with biotinylated horse anti-mouse secondary antibody (1:1000, Vector Laboratories, Burlingame, CA, USA), followed by tyramide-signal amplification with the indocarbocyanine as the fluorophore (Perkin-Elmer, Waltham, MA, USA). After washes, tissues were incubated with donkey anti-goat secondary antibody (Alexa Fluor 488, Thermo Fisher Scientific) at room temperature for 2 h. After final washes, tissues were mounted on slides with anti-fade solution (Thermo Fisher Scientific) and coverslipped.
Another set of tissues were stained with 3,3'-diaminobenzidine (DAB). After antigen retrieval in citrate solution (pH 6.0) at 80°C for 40 min, tissues were treated with freshly made 1% H 2 O 2 for 30 min at room temperature to reduce endogenous peroxide background. The tissues were blocked in 5% normal goat serum (NGS) and incubated with mouse anti-A 2A receptor antibody at 4°C overnight. Following washing, tissues were incubated with biotinylated goat anti-mouse secondary antibody (1:1000; Vector Laboratories) and 2.5% NGS in 0.1% TBS-Tx at room temperature for 1 h. After washes, tissues were incubated in avidin-biotin-complex solution (PK-6100, Vector Laboratories) for 1 h at room temperature followed by DAB solution (SK-4100, Vector Laboratories). Tissue sections were washed, mounted on slides and coverslipped.
Acquisition of representative images and verification of receptor colocalization were performed using a spinning disk confocal fluorescence microscope (Olympus IX2-DSU, Olympus Corp., Tokyo, Japan). Slides were illuminated via Prior Lumen 200 mercury metal halide lamp (Prior Scientific, Inc., Rockland, MA, USA). For CtB and NeuN, an excitation filter of 472/30 nm and an emission filter of 520/35 nm were used (Semrock Brightline GFP-3035-B, Semrock, Inc., Rochester, NY, USA). For A 2A receptor immunolabelling, an excitation filter of 562/40 nm and an emission filter of 624/40 nm were used (Semrock Brightline TxRed-4040B). Both 20× and 40× lenses were used for imaging (UPLSAPO 20× and 40×, Olympus). Excitation duration was 500 ms for CtB and A 2A receptor channels, and 400 ms for NeuN channel. Gain setting was zero (No gain). Neutral density was set to 1.
Step size was 1 μm. No binning was performed. The same light exposures were used for both groups.
For quantitative fluorescence studies, slides were imaged using a fluorescence/brightfield microscope (BZ-X710, Keyence Co., Osaka, Japan) with a 20× lens (catalogue no: 971962, Keyence). A 2A receptor immunolabelling was detected using a TexasRed filter (BZ-X, model no: OP-87765), whereas CtB immunolabelling was detected via a GFP filter (BZ-X, model no: OP-87763). NeuN immunolabelling was detected via a DAPI filter (BZ-X, model no: OP-87762). The same light exposures were used for both groups. Exposure times were 1/3 s, 1/120 s, and 1/10 s for A 2A receptors, CtB and NeuN, respectively.
Step size was 2 μm.
Image quantification
Fluorescence was analysed using images localized to the CtB-labelled area of the ventral horn. CtB-positive areas were determined using an adaptive threshold algorithm custom written in Matlab (The Mathworks, Natick, MA, USA). First, background intensity level was determined using the median value of a control region (immediately towards the central canal for each side). Second, a threshold for each CtB image was determined by constructing a pixel intensity histogram for each image and selecting a fixed percentile value across all images. By selecting a fixed percentile value across images, the changes in signal and background intensities were accounted for. For example, using the same percentile value in an image with higher signal and background intensities would produce a higher threshold, yielding better discrimination compared to the fixed threshold method. Thus, this method utilizes an unbiased adaptive thresholding method, which compensates for potential animal-to-animal and image-to-image differences due to different factors (e.g. tissue fixation, tissue depth of the cells being imaged, etc.). Then, CtB-positive areas were masked based on the adaptive threshold such that the CtB-positive areas were assigned the value of unity, whereas the rest were assigned zero. The centre of gravity was calculated for each image based on the binary values using the following formula:
where G is the centre of gravity, p i is the binary value of each pixel after thresholding (i.e. 0 or 1), and r i (x, y) is the position/coordinate of each pixel in the transverse plane. Intensity of the A 2A receptor labelling was calculated as the average immunolabelling intensity of the CtB-positive areas and normalized to control group values. DAB-stained images were analysed to validate the fluorescence technique as follows. Phrenic motor neurons were located as a cluster of large, mediolateral neurons in the cervical ventral horn (Boulenguez et al. 2007; Mantilla et al. 2009; Watson et al. 2009 ). Optical density of the A 2A receptor labelling, background and signal-to-background ratio were calculated for each region of interest. Phrenic nucleus intensity was calculated using a circular region of interest (diameter: 100 μm). As shown in Fig. 1B , background for phrenic motor neurons was measured at the area immediately dorsomedial to the phrenic motor nucleus.
A 2A receptor co-localization with NeuN was assessed by computing the binarized images of each protein. In NeuN, the images were thresholded at the 80th percentile and an image mask was created. The A 2A receptor image was first thresholded and binarized relative to 1.5 times the image background intensity (median value). Colocalization was measured as the percentage of A 2A receptor-positive areas co-localizing with NeuN versus total A 2A receptor-positive areas.
In addition to fluorescence co-localization studies, intensities of individual non-phrenic motor neurons (area of soma >300 μm 2 ) at lamina IX were calculated using ImageJ (NIH, Bethesda, MD, USA). A 2A receptor labelling in non-phrenic cervical motor neurons was measured to assess potential non-specific siRNA effects. Similar to phrenic motor neurons, the immediate dorsomedial area was used to measure background intensity for non-phrenic motor neurons. Data were averaged for each rat, representing the measured value for that animal. Lastly, to evaluate if nearby non-phrenic motor neurons were affected by the siRNA treatment, the distance (d) of each non-phrenic motor neuron to the centre of gravity of phrenic nucleus was calculated as shown in Fig. 1B .
Neurophysiology experiments
For terminal neurophysiological experiments, anaesthesia was induced with 3% isoflurane in O 2 and maintained with 3% isoflurane in 60% O 2 ; the inspired CO 2 fraction delivered was set such that the end-tidal CO 2 was ß42 mmHg (balance N 2 ). Body temperature was measured rectally and maintained with a custom-made heated surgical table. Rats were tracheostomized and mechanically ventilated at 70 breaths min −1 for the rest of the experiment (2.5 ml, Rodent Ventilator, model 683, Harvard Apparatus, South Natick, MA, USA). To eliminate ventilatory entrainment, bilateral vagotomy was performed. To measure blood pressure and sample arterial blood for blood gas analysis, the right femoral artery was catheterized. Rats were rotated from supine to prone position and converted from isoflurane to urethane anaesthesia (2.1 g kg −1 , I.V. tail vein) within 20 min. The left phrenic nerve was isolated, distally cut, desheathed and placed into custom-made glass suction electrodes. Rats were subjected to neuromuscular blockade with pancurorium bromide (3 mg/kg, i.v.). End tidal CO 2 was measured using a flow-through capnograph (Capnogard, Novametrix; Wallingford, CT, USA). Arterial blood gases, pH and base excess were monitored (ABL, Radiometer, Copenhagen, Denmark). Sodium bicarbonate and lactated Ringer solution (1:4) were administered I.V. (0.5-1.5 ml h −1 ). Phrenic nerve activity was amplified (10,000×; A-M Systems, Everett, WA, USA), band-pass filtered (300-5000 Hz), rectified and integrated using a Paynter filter with a time constant of 50 ms (CWE 821, Ardmore, PA, USA). Raw signals were digitized and stored at 25 kHz (Spike 2, CED, Cambridge, UK). Phrenic burst amplitude was normalized to baseline levels. Phrenic burst frequency was analysed using integrated values. Phrenic burst frequency and amplitude were analysed in 60 s time periods preceding blood samples. Data were included if (1) P aCO 2 was maintained ±1.5 mm Hg of baseline levels, (2) base excess was within ±3 mEq l −1 , and (3) mean arterial pressure was maintained ±30 mmHg of baseline levels. Baseline values were determined ß1 h after anaesthetic conversion to urethane, and at the P aCO 2 level 2 mmHg above the recruitment threshold.
The A 2A receptor agonist CGS21680 was dissolved at 50 μM in 10% DMSO (balance sterile saline) and administered intrathecally over the C3-4 segment. Total CGS21680 volume (30 μl) was administered in three injections. Each injection (10 μl) was delivered over 2 min and was separated by 5 min.
Data analysis and statistics
Regression analyses were performed by comparing d vs. optical density and d vs. signal-to-background ratio. Data presented in Figs 2, 3 and 5 were averaged within each experimental condition and animal to represent the sample for that experimental condition per animal. Statistical analyses of molecular data were performed using ANOVA. When ANOVA presented differences, post hoc analyses were performed using the Tukey-Kramer honest significant difference. Data for each group were summarized as mean ± standard error of the mean. Electrophysiological data were analysed using two-way repeated measures ANOVA. One animal in the siA 2A group of electrophysiology studies was classified as an outlier according to Grubbs's test and excluded from analyses. Tukey's honest significant difference test was used for post hoc analysis. Statistical calculations were performed using JMP 11.0 (SAS Institute, Cary, NC, USA). Significance level was set at 0.05 for all statistical comparisons.
Results
A 2A receptor expression in CtB-positive phrenic motor neurons
A 2A receptor labelling was significantly co-localized (89 ± 2%) with NeuN-positive neurons. Phrenic motor neurons were identified via retrograde CtB labelling following intrapleural CtB injections. Abundant A 2A receptor labelling was observed in the cytoplasm and on the membrane of phrenic motor neuron somata ( Fig. 2A-F A 2A receptor expression was assessed within CtB-labelled phrenic motor neurons for the siNT and siA 2A groups. Optical density (44%) and signal-to-background ratio (45%) at the phrenic motor nucleus were lower in siA 2A versus siNT treated rats ( Fig. 2E and F ; P < 0.05). No significant difference was observed in background intensities across groups in the region medio-dorsal to the phrenic motor nucleus.
In the absence of glial staining, potential non-specific effects of siA 2A were assessed by measuring A 2A receptor labelling in nearby non-phrenic motor neurons. No changes in optical density or signal-to-background ratio were evident in non-phrenic cervical motor neurons ( Fig. 3A and B) . Potential local effects of siRNAs on non-phrenic motor neurons were also evaluated by correlating A 2A receptor expression on non-phrenic motor neurons versus the distance of the non-phrenic motor neuron to the centre of gravity of phrenic motor nucleus. No differences were observed across groups (Fig. 4) .
siA 2A attenuates A 2A receptor-induced phrenic motor facilitation
A 2A receptor agonists administered intrathecally give rise to pMF (Golder et al. 2008; Agosto-Marlin et al. 2017) . To confirm that the relevant A 2A receptors leading to A 2A R-induced pMF are on the phrenic motor neurons, we compared the amplitudes of A 2A R-induced pMF between siNT and siA 2A treated rats, where P aO 2 , P aCO 2 , base excess, body temperature and blood pressure were stable throughout the recordings (Table 1) . pMF was ß147% in siNT treated rats 90 min post-intrathecal CGS21680 administration (Fig. 5B) . However, in the siA 2A group, pMF was significantly lower than in the siNT group (21%, P < 0.01). A 2A receptor induced pMF was marginally different from baseline P = 0.07) in the siA 2A treated group. No significant changes in phrenic burst frequency were observed between siNT and siA 2A treated rats (Fig. 5C ).
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Discussion
Adenosinergic mechanisms differentially regulate multiple forms of neuroplasticity in the central nervous system (Golder et al. 2008; Hoffman et al. 2010; Nichols et al. 2012; Orr et al. 2015) . At least some of these differential effects result from A 2A receptor activation on different cell types (Orr et al. 2015) . Since spinal A 2A receptors play a key role in phrenic motor plasticity, studying the cellular localization of relevant A 2A receptors is important. We hypothesized that A 2A receptors relevant to the A 2A -receptor-induced pMF are expressed in phrenic motor neurons versus interneurons or nearby glia. Important findings include the following: (1) A 2A receptors are highly expressed in motor neurons (including phrenic motor neurons) versus other cell types in the cervical spinal cord; and (2) intrapleural siA 2A injections selectively knock down A 2A receptor expression in phrenic motor neurons and strongly attenuate A 2A receptor-induced pMF. Thus, we conclude that the relevant receptors for A 2A receptor-induced pMF are within phrenic motor neurons per se, at least in normal rats.
Phrenic motor facilitation requires phrenic motor neuron A 2A receptors
Neuromodulators such as adenosine and serotonin play complex and important roles in the modulation of phrenic motor output through Gs-and Gq-protein-coupled signalling pathways (Baker-Herman et al. 2004; Golder et al. 2008; Hoffman & Mitchell, 2011; MacFarlane et al. 2011; Fields et al. 2015) . Activation of Gs-protein-coupled receptors via A 2A or 5HT7 receptors elicits pMF by a mechanism known as the S pathway (Golder et al. 2008; Hoffman & Mitchell, 2011; Fields et al. 2015) . The S pathway constrains Gq-protein-coupled pMF (the Q pathway) due to powerful cross-talk inhibition (Devinney et al. 2015; Fields et al. 2015; Dale et al. 2017) . Thus, understanding A 2A receptor regulation of phrenic motor neurons is highly significant.
We found that A 2A receptors are highly expressed in the cytoplasm and on cell membranes of motor neuron somata in the C3-5 spinal cord, including identified phrenic motor neurons. receptors in any model of plasticity, since their role in neuroplasticity is highly cell specific. For example, neuronal A 2A receptors on hippocampal CA3 pyramidal cells are essential for some forms of hippocampal long-term potentiation (Rebola et al. 2008) , whereas astrocytic A 2A receptors impair memory formation in ageing mice (Orr et al. 2015) . Thus, it is critical to address cell types expressing relevant A 2A receptors in any model of neuroplasticity.
Here, we show that knock-down of phrenic motor neuron A 2A receptors abolishes A 2A receptor-induced pMF, suggesting that the relevant A 2A receptors for this form of pMF are located on phrenic motor neurons. This finding is of particular interest under physiological challenges, such as hypoxia, when ATP/adenosine levels are increased in the extracellular space (Gourine et al. 2005; Martín et al. 2007) , and are necessary for forms of plasticity such as phrenic long-term facilitation following severe acute intermittent (Nichols et al. 2012) or sustained hypoxia (Devinney et al. 2016) . We conclude that these A 2A -receptor-dependent forms of phrenic motor plasticity require receptor activation on phrenic motor neurons versus other cells.
The present findings are consistent with our working model, in which strong spinal Gs-protein-coupled receptor activation elicits pMF by an exchange protein activated by cAMP (EPAC)-dependent mechanism . Although both protein kinase A (PKA) and EPAC can be activated by cAMP formed on A 2A receptor activation, the cAMP threshold for PKA is much lower than that for EPAC (Ponsioen et al. 2004; Zhou et al. 2016) ; thus, even modest reductions in A 2A receptor expression and cAMP formation could eliminate EPAC signalling without abolishing PKA activation. Because of this differential cAMP threshold, EPAC-dependent pMF may be abolished by even modest reductions in A 2A -induced cAMP formation, without losing the capacity for PKA-dependent inhibition of pMF elicited by Gq-proteincoupled receptor activation .
In molecular analyses of A 2A receptor expression, the only observed difference was a knock-down (not knock-out) of A 2A receptor labelling in the phrenic motor nucleus, which contains somas and tightly packed dendritic projections. In contrast, non-phrenic motor neurons at the same cervical levels did not change A 2A receptor expression regardless of their proximity to the phrenic nucleus. Since it is more difficult to discern changes in synapses on the distal dendrites, we cannot completely rule out distal dendrite contributions in these cells. Nevertheless, we did not see any evidence for A 2A . Total CGS21680 volume (30 µl) was given in 3 injections (10 µl), each delivered over 2 min, separated by 5 min. B, percentage change in phrenic burst amplitude at baseline and 30, 60 and 90 min after the last injection. Rats given intrapleural siNT showed phrenic motor facilitation (pMF), but this effect was attenuated and no longer significant in rats given intrapleural siA 2A . C, no changes observed in phrenic burst frequency, suggesting that the drug effects were localized to the spinal cord. * P < 0.05 versus non-targeting siRNA, †P < 0.05 versus baseline of the same group. (Navarrete-Opazo et al. 2015) . On the other hand, with more chronic spinal injuries (>8 weeks), rAIH-induced functional recovery switches to a serotonin-dependent, adenosine-constrained mechanism Navarrete-Opazo et al. 2017) . This shift likely arises from serotonergic reinnervation below the injury; shifting expression patterns of A 2A receptors could also contribute to these complex results.
Spinal cell type-specific A 2A receptor expression may be of particular interest in certain pathologies. For example, astrocytic A 2A receptor expression is upregulated in some murine models of Alzheimer's disease (Orr et al. 2015) ; in these models, genetic knock-out of astrocytic A 2A receptors preserves memory. Little is known concerning cell-specific A 2A receptor expression in pathologies impacting breathing, such as spinal injury and motor neuron diseases. However, in preliminary experiments, we observed profound upregulation of astrocytic A 2A receptors at disease end-stage in SOD1
G93A mutant rats, a rodent model of amyotrophic lateral sclerosis (Y. B. Seven and G. S. Mitchell, unpublished). Thus, the specific role of A 2A receptors in spontaneous or induced phrenic motor plasticity may change with injury and/or disease, a possibility that warrants further investigation. Although A 2A receptor signalling plays a significant role in regulating phrenic motor plasticity, further studies are needed to reveal details concerning the cell types mediating their effects, and their involvement in spontaneous and induced functional recovery after injury or during disease.
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Translational perspective
Adenosine receptors play an important role in CNS plasticity. For example, cervical spinal adenosine 2A (A 2A ) receptor activation via severe intermittent hypoxia or A 2A receptor agonist injections elicits a prolonged increase in phrenic nerve activity known as phrenic motor facilitation (pMF). Thus, cervical spinal A 2A receptors represent a therapeutic target to enhance respiratory function with neuromuscular disorders that compromise breathing. Physiological outcomes of A 2A receptor activation depend on the specific cell types expressing these receptors, yet the specific cervical spinal cells expressing relevant A 2A receptors are unknown. We tested the hypothesis that A 2A receptors relevant for pMF are expressed within phrenic motor neurons versus interneurons or nearby glia. A 2A receptor-mediated signalling has been identified as a therapeutic target to treat pathophysiological conditions in which increased motor neuron excitability is desired such as spinal cord injury or motor neuron disease. Following cervical spinal cord injury, reduced excitatory input to the phrenic motor neurons can be compensated by A 2A receptor upregulation or activation of down-stream signalling cascades in phrenic motor neurons (e.g. via gene therapy). Moreover, the effects of commonly used adenosine receptor antagonists, such as caffeine and theobromine, may undermine neuroplasticity in specific pathological states.
